Mayo Clinic study links blood marker to future cognitive decline risk
A Mayo Clinic study in JAMA Neurology reports that a blood test measuring p-tau217 in 2,178 cognitively unimpaired adults ages 60–90 could help estimate risk of cognitive decline within five to 10 years, but is not ready for routine screening.
This is HUB News’s original summary. Read the complete report at Fox News.